Shares of United Therapeutics Corporation (UTHR) are climbing about 9 percent on Wednesday morning trading following the announcement of its fourth-quarter financial results, which revealed earnings of $364.3 million, or $7.70 per share, up from last year's $301.3 million, or $6.19 per share.
The company's stock is currently trading at $516.11, up 9.02 percent or $42.68, over the previous close of $473.43 on the Nasdaq. It has traded between $266.98 and $530.00 in the past one year.
The company's revenue for the period rose 7.4 percent, to $790.2 million from $735.9 million last year.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.